Conference
Phase II study of Sorafenib (BAY 43-9006) in combination with Gemcitabine in recurrent epithelial ovarian cancer - a study of the PMH phase II consortium
Authors
Townsley C; Hirte H; Sharma S; Pond G; Tinker L; Afinec A; Wright J; Oza AM
Volume
3
Pagination
pp. 272-272
Publisher
PERGAMON-ELSEVIER SCIENCE LTD
Publication Date
October 1, 2005
Conference proceedings
EJC SUPPLEMENTS
Issue
2
ISSN
1359-6349